Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

REDD1 Is a Promising Therapeutic Target to Combat the Development of Diabetes Complications: A Report on Research Supported by Pathway to Stop Diabetes

Diabetes(2024)10.2337/dbi24-0013Source: DataRank Database

REDD1 Is a Promising Therapeutic Target to Combat the Development of Diabetes Complications: A Report on Research Supported by Pathway to Stop Diabetes is a research paper published in Diabetes (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.96)OA: bronzeTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Michael D. Dennis ORCID,Siddharth Sunilkumar ORCID

Live enrichment

PubMed:38976480 PMC:PMC11417436 OpenAlex:https://openalex.org/W4400412615

Juvenile Diabetes Research Foundation

Grant: 1-INO-2024-1538-A-N

National Eye Institute

Grant: R01EY029702

National Eye Institute

Grant: R01EY032879

National Eye Institute

Grant: R21EY035844

American Diabetes Association

Grant: 1-14-INI-04

American Diabetes Association

Grant: 11-23-PDF-84

FWCI

2.96

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: https://www.diabetesjournals.org/journals/pages/license

journalhttps://diabetesjournals.org/diabetes/article-pdf/73/10/1553/782324/dbi240013.pdf

publisherhttps://diabetesjournals.org/diabetes/article-pdf/73/10/1553/782324/dbi240013.pdf

journalhttps://doi.org/10.2337/dbi24-0013

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38976480

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11417436

Fields of Study

Advanced Glycation End Products researchEndoplasmic Reticulum Stress and DiseaseGlutathione Transferases and PolymorphismsHumansTranscription FactorsAnimalsDiabetes ComplicationsSignal TransductionDiabetes Mellitus, Type 2Oxidative StressDiabetes Mellitus, Type 1

MeSH Terms

AnimalsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HumansTranscription FactorsSignal TransductionOxidative StressDiabetes Complications

Keywords

Diabetes mellitusOxidative stressType 2 diabetesMedicineInflammationmTORC1InsulinDiseaseSignal transductionPrediabetesBioinformaticsProtein kinase BEndocrinologyInternal medicineBiologyCell biology

Sustainable Development Goals

SDG 0: Good health and well-being